313 related articles for article (PubMed ID: 32677040)
1. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
Frandsen LT; Westmark S; Melgaard D; Krarup AL
United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice.
Laserna-Mendieta EJ; Casabona S; Savarino E; Perelló A; Pérez-Martínez I; Guagnozzi D; Barrio J; Guardiola A; Asensio T; de la Riva S; Ruiz-Ponce M; Rodríguez-Oballe JA; Santander C; Arias Á; Lucendo AJ;
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2903-2911.e4. PubMed ID: 31988045
[TBL] [Abstract][Full Text] [Related]
4. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
5. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
[TBL] [Abstract][Full Text] [Related]
7. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
Moawad FJ; Schoepfer AM; Safroneeva E; Ally MR; Chen YJ; Maydonovitch CL; Wong RK
Aliment Pharmacol Ther; 2014 Mar; 39(6):603-8. PubMed ID: 24461332
[TBL] [Abstract][Full Text] [Related]
9. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
10. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
Molina-Infante J; Katzka DA; Gisbert JP
Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis: Predictive Factors and Long-Term Step-Down Efficacy.
Gutiérrez-Junquera C; Fernández-Fernández S; Domínguez-Ortega G; Vila Miravet V; García-Puig R; La Orden-Izquierdo E; Peña Quintana L; Barrio Torres J; Medina Benítez E; Leis R; García-Romero R; Fernández de Valderrama A; Vecino López R; Donado Palencia P;
J Pediatr Gastroenterol Nutr; 2023 Feb; 76(2):191-198. PubMed ID: 36416845
[TBL] [Abstract][Full Text] [Related]
12. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
Eur J Pediatr; 2024 May; ():. PubMed ID: 38819501
[TBL] [Abstract][Full Text] [Related]
13. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
Dohil R; Newbury RO; Aceves S
Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
[TBL] [Abstract][Full Text] [Related]
15. The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon.
Savarino EV; Tolone S; Bartolo O; de Cassan C; Caccaro R; Galeazzi F; Nicoletti L; Salvador R; Martinato M; Costantini M; Savarino V
Aliment Pharmacol Ther; 2016 Sep; 44(5):522-30. PubMed ID: 27373195
[TBL] [Abstract][Full Text] [Related]
16. Conservative long-term treatment of children with eosinophilic esophagitis.
Levine J; Lai J; Edelman M; Schuval SJ
Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
[TBL] [Abstract][Full Text] [Related]
17. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
[TBL] [Abstract][Full Text] [Related]
18. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
[TBL] [Abstract][Full Text] [Related]
19. CYP2C19 and STAT6 Variants Influence the Outcome of Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis.
Mougey EB; Williams A; Coyne AJK; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Román E; González Lois C; Chao M; Al-Atrash H; Lima JJ; Franciosi JP
J Pediatr Gastroenterol Nutr; 2019 Nov; 69(5):581-587. PubMed ID: 31490856
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis.
Molina-Infante J; Bredenoord AJ; Cheng E; Dellon ES; Furuta GT; Gupta SK; Hirano I; Katzka DA; Moawad FJ; Rothenberg ME; Schoepfer A; Spechler SJ; Wen T; Straumann A; Lucendo AJ;
Gut; 2016 Mar; 65(3):524-31. PubMed ID: 26685124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
